You are here: Industry Insights > COVID-19

News List

ModeX Therapeutics Leverages ProBioGen's Expertise for Accelerated COVID-19 Antibody Development PharmaSources
May 30, 2024
ModeX will harness the power of ProBioGen's pioneering DirectedLuck® Transposase Technology, which enables the production of high-titer, stable expression cell lines that are critical to the success of ModeX's antibody program.
WHO Publishes Updated List of COVID-19 Medicines, APIs SHEM OIRERE
May 05, 2023
The coronavirus disease 2019 (COVID-19) infections and deaths continue to be reported across the globe creating demand for more appropriate medicines and associated active pharmaceutical ingredients.
Pharma Sources Insight June 2022: New Developments of COVID-19, Greater Impact on the Pharma Market Pharma Sources Insight
May 22, 2022
Pharma Sources Insight June 2022 focuses on new developments of COVID-19, and greater impacts it brings to the Pharma Market.
With First Chinese Small-molecule Oral Drug for COVID-19 Coming, What New Opportunities are Ushered in by the Relevant Industry Chain？ PharmaSources.com/Yefenghong
May 23, 2022
News about the progress of Chinese small-molecule oral antiviral drug for COVID-19 has been disclosed in recent days and the related R&D ushers in a critical point.
Outlook for Covid-19 in the Second Half of 2022 and its Broader Impact on the Pharma Market Dr. Preet Pal S.B.
May 22, 2022
The initial shock of Omicron is over, and it appears that the covid-19 cases are declining globally.
A Look at the Export Status of Chinese COVID-19 Vaccine in 2021 PharmaSources/Xiaoyaowan
March 30, 2022
According to reports, the cumulative value of China’s human vaccine exports reached RMB 101.04 billion in 2021.
To Win the Fight against COVID-19 in the Future, How To Make a Breakthrough in the R&D of New Drug? PharmaSources/Professor in medical field
March 21, 2022
Recently, with the continuous evolution and spread of Novel Coronavirus variant (including Delta-related variant viruses) all over the world, the mortality rate in some areas has a tendency to increase.
FDA Stops Two COVID-19 Rapid Diagnostics Tests Lin Zhang
March 01, 2022
The coronavirus (COVID-19) pandemic has been around for more than two years. While in many ways the world is returning to normal, the wave of Omicron and continued cases of COVID-19 still need to be addressed.
Fighting Against COVID-19: Summary of Key Products PharmaSources/Recollect
February 22, 2022
Since the outbreak of COVID-19 in 2019, many kinds of COVID-19 vaccines, COVID-19 preventive drugs and COVID-19 therapeutic drugs have been approved worldwide.
Increased COVID-19 testing triggers demand for kit reagents Shem Oirere
February 22, 2022
The emerging new mutations of COVID-19 is fueling the global drive for mass testing hence increasing demand for reagents for both testing kits and vaccine production especially in low- and middle-income countries.